105 episodes

The MTPConnect Podcast Series connects with the people and the issues behind Australia’s growing medical technologies, biotechnologies and pharmaceuticals sector.

The MTPConnect Podcast MTPConnect

    • Science
    • 5.0 • 20 Ratings

The MTPConnect Podcast Series connects with the people and the issues behind Australia’s growing medical technologies, biotechnologies and pharmaceuticals sector.

    Partnering in the age of COVID: Real World Tips from SpeeDx

    Partnering in the age of COVID: Real World Tips from SpeeDx

    In this episode, we take you to our recent Collaboration and Skills Summit where we brought together a panel of industry experts to share their tips and experiences on how to maximise virtual partnering success at biotech conferences and meetings. 
    You will hear from Colin Denver, CEO of SpeeDx Pty Ltd,  an Australian diagnostics company developing tests for infectious diseases including COVID-19. Colin shares his top tips for raising capital as a small company and doing deals online in the age of COVID-19.
    If you are seeking new strategic partnerships for funding or collaboration this episode is packed full of helpful insights.  
    SpeeDx is supported with funding from MTPConnect’s Biomedical Translation Bridge (BTB) Program. 

    • 18 min
    Clinical Trials in Australia: opportunities for growth

    Clinical Trials in Australia: opportunities for growth

    In this episode, we take you to the launch of our new report into Australia’s Clinical Trials sector held on International Clinical Trials Day in Melbourne.  MTPConnect brought together a panel of thought leaders to discuss the importance of clinical trials.
    Hear insights from our esteemed panel chaired by Dr Dan Grant, MTPConnect's Managing Director and CEO.
    Carrie Bloomfield, Co-Chair,  R&D Taskforce, and Director Clinical Operations  GlaxoSmithKline AustraliaDr Janelle Bowden, Managing Director AccessCRDr Megan Robertson, Group Chief Research Officer @St Vincent’s Health Australia, and Chair AusBiotech Clinical Trial Advisory GroupProf John Zalcberg, Head, Cancer Research Program Monash UniversityDr Rebecca Tunstall, Senior Director Stakeholder Engagement  MTPConnectMTPConnect's report 'Australia’s Clinical Trials Sector: Advancing innovative healthcare and powering economic growth' has been developed in partnership with L.E.K Consulting and will provide an essential reference for the sector. Download the report at www.mtpconnect.org.au/reports.

    • 50 min
    Partnering in the age of COVID: Real World Tips from Dimerix

    Partnering in the age of COVID: Real World Tips from Dimerix

    In this episode we take you to our recent Collaboration and Skills Summit where we brought together a panel of industry experts to share their tips and experiences on how to maximise virtual partnering success at biotech conferences and meetings. 
    You will hear from Dr Nina Webster, the Managing Director & CEO of Dimerix Limited who shares the highs and lows of forming relationships and doing deals online in the age of COVID-19.
    If you are seeking new strategic partnerships for funding or collaboration this episode is for you. 

    • 18 min
    Are you a medtech or pharma startup? The 2021 Australian Technologies Competition wants you!

    Are you a medtech or pharma startup? The 2021 Australian Technologies Competition wants you!

    This week’s edition of the MTPConnect podcast checks in with the Australian Technology Competition - Australia's national Competition, late-stage accelerator and partnerships program designed to identify and accelerate homegrown scaleups with global potential. Last year, Electrogenics Laboratories won the Australian Technology Company of the Year and also took out the Medtech and Pharma Award, for developing its MOSkin Sensor Technologies, an affordable wireless radiation sensor technology that precisely measures radiation skin doses. Host Shannan Osrin meets their Executive Chairman Kim Lyle who looks back on the impact of the win and the experiences gained, and shares tips on start-up success. Also joining the discussion is Patrick Mooney, Chair of Impact Tech Ventures, the organiser of the Competition. Now in its 11th year, the Competition is supported by the Department of Industry, Science, Energy and Resources, MTPConnect and other Industry Growth Centres, and industry partners. Entries are now open for the Competition in eleven categories, including the Medtech & Pharma Award, and close on 10 May 2021. 

    • 22 min
    Part 2: The Inflazome Story - the research, the deal and scientists that made it happen

    Part 2: The Inflazome Story - the research, the deal and scientists that made it happen

    Tune in for part 2 of our 100th episode special, following our chat with Professor Kate Schroder, head of the Inflammasome Laboratory and Director of the Centre for Inflammation and Disease Research at the Institute for Molecular Bioscience (IMB), University of Queensland and Professor Ian Henderson, the Director of IMB. We explore the story behind the milestone research discovery that could lead to a treatment for conditions like Parkinson’s and Alzheimer’s disease, Motor Neurone Disease – even asthma. The innovation was developed out of the UQ, in partnership with Trinity College in Dublin. And the start-up company spawned by the research – Inflazome - was recently acquired by Roche in a deal worth around $600 million, making it one of Australia’s largest ever biotech deals. We also explore the broader work of IMB and the international collaborative approach underpinning its research successes.

    • 25 min
    The Inflazome Story: the research, the deal and scientists that made it happen

    The Inflazome Story: the research, the deal and scientists that made it happen

    Happy 100th episode subscribers! We bring you part 1 of a special double episode following our chat with Professor Kate Schroder, head of the Inflammasome Laboratory and Director of the Centre for Inflammation and Disease Research at the Institute for Molecular Bioscience (IMB), University of Queensland and Professor Ian Henderson, the Director of IMB. We explore the story behind the milestone research discovery that could lead to a treatment for conditions like Parkinson’s and Alzheimer’s disease, Motor Neurone Disease – even asthma. The innovation was developed out of the UQ, in partnership with Trinity College in Dublin. And the start-up company spawned by the research – Inflazome -- was recently acquired by Roche in a deal worth around $600 million, making it one of Australia’s largest ever biotech deals. We also explore the broader work of IMB and the international collaborative approach underpinning its research successes.

    • 26 min

Customer Reviews

5.0 out of 5
20 Ratings

20 Ratings

BLTrack ,

Very informative !

They do a great job of letting the speaker speak without interjecting, and looking for key learnings. Good stuff !

spresto0 ,

Hidden Gem

Awesome to have something like this up and running in Australia. Great way to help bridge the gap in knowledge between researchers and industry.

sralophie ,

Inspirational

Why a great podcast, learning about inspirational people in our medical industry.

Top Podcasts In Science

Listeners Also Subscribed To